Associated Papers
Retromer stabilization using a pharmacological chaperone protects in an α-synuclein based mouse model of Parkinson's.
Eleuteri S et al.
Research Square, 2023
Mechanisms of VPS35-Mediated Neurodegeneration in Parkinson's Disease.
Sargent D et al.
International Review of Movement Disorders, 2021
VPS35, the core component of the retromer complex, and Parkinson's disease.
Luo AD et al.
Ibrain, 2021
Atypical parkinsonism of progressive supranuclear palsy-parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology.
Menšíková K et al.
Acta Neuropathologica, 2019
Familial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes: A case report.
Bartonikova T et al.
Medicine, 2016
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.
Zimprich A et al.
American Journal of Human Genetics, 2011
Select a paper to view details